FreeStyle Libre flash glucose monitoring system

DexCom, Inc. (NASDAQ: DXCM) shares got hammered Sept. 28 when rival Abbott Laboratories (NYSE: ABT) received FDA approval for its FreeStyle Libre flash glucose monitoring system. Investors see Abbott’s new system as a lower-priced alternative to DexCom’s continuous glucose...